Table 4

KRAS genotype frequencies and HR status and HER2 status according to HRT stratification

Study population

Genotype

Frequency

p

Frequency p

p

N(%)

value

N(%)

value



HR+

HR-

HER2+

HER2-


All

wild(TT)

363(82.9)

69(83.1)

0.955

49(77.8)

372(84.0)

0.218


variable(TG/GG)

75(17.1)

14(16.9)

14(22.2)

71(16.0)


Nonusers: HRT < 1 year

wild(TT) variable(TG/GG)

250(81.7) 56(18.3)

52(85.2) 9(14.8)

0.508

41(83.7) 8(16.3)

255(82.8) 53(17.2)

0.879


Users: HRT 1 years

wild(TT)

113(85.6)

17(77.3)

0.318

8(57.1)

117(86.7)

0.004


variable(TG/GG)

19(14.4)

5(22.7)

6(42.9)

18(13.3)


Statistically significant results are shown in bold

Cerne et al. BMC Cancer 2012 12:105   doi:10.1186/1471-2407-12-105

Open Data